MedPath
NMPA Approval

Sacituzumab Govitecan for Injection

国药准字SJ20220015

June 7, 2022

Drug Information

注射用戈沙妥珠单抗

拓达维

注射剂

180mg/瓶

生物制品

June 7, 2022

June 6, 2027

Company Information

Applicant Company

吉利德科学

333 Lakeside Drive, Foster City, CA 94404 United States of America

Manufacturing Company

Via Appia km 65, 561, Latina Scalo, Latina 04013 ITALY

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用戈沙妥珠单抗 - NMPA 批准文号 | MedPath